News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Stephen G. Ball, PhD

Articles by Stephen G. Ball, PhD

Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients

ByStephen G. Ball, PhD

January 1st 1996

Latest Updated Articles

Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients
Published: January 1st 1996 | Updated:

Trending on AJMC

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

Patients Face New Care Complexities as DTC Options Expand

FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population

FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

Louisiana Delivers Innovative Cancer Treatments, but Ensuring Access Is a Work in Progress

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.